Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation

Roche, B; Samuel, D; Gigou, M; Feray, C; Virot, V; Majno, Pietro; Serraf, L; David, M F; Dusseaix, E; Reynes, M; Bismuth, H

doi:10.1016/S0168-8278(99)80335-3

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation
Authors		Roche, B Samuel, D Gigou, M Feray, C Virot, V Majno, Pietro Serraf, L David, M F Dusseaix, E Reynes, M Bismuth, H show all authors [1 - 11]
Published in		Journal of Hepatology. 1999, vol. 31, no. 4, p. 584-92
Abstract		Hepatitis B virus (HBV) disease on a liver graft is associated with florid viral replication and graft failure. The aim of this study performed between 1992 and 1995 was to investigate the safety and efficacy of long-term intravenous ganciclovir for HBV infection in liver transplant recipients.
Keywords		Adult — Antiviral Agents/adverse effects/therapeutic use — DNA, Viral/analysis — Female — Ganciclovir/adverse effects/therapeutic use — Hepatitis B/drug therapy/immunology/pathology — Hepatitis B Antigens/analysis — Hepatitis B virus/genetics — Humans — Liver/pathology — Liver Transplantation — Male — Middle Aged — Postoperative Complications/drug therapy — Prospective Studies — Time Factors — Treatment Outcome
Identifiers		DOI: 10.1016/S0168-8278(99)80335-3 PMID: 10551379
Full text		Article (Published version) (1.1 MB) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research group		Hépatologie chirurgicale (327)
Citation (ISO format)		ROCHE, B et al. Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation. In: Journal of Hepatology, 1999, vol. 31, n° 4, p. 584-92. doi: 10.1016/S0168-8278(99)80335-3 https://archive-ouverte.unige.ch/unige:73132